Covid-19: beyond the current crisis
Our lives have been transformed by Covid-19, and in the short term, they will change still yet. But what will happen after this pandemic...
Birth beyond borders
The patchwork of regulation governing IVF treatment in Europe could be seen as a significant barrier to IVF providers looking to build pan-European brands,...
Reshaping cancer diagnosis and care pathways in the UK
A new generation of highly predictive biomarkers are being developed and launched to revolutionise the diagnosis and prognosis of cancer. Candesic’s Dr Chris Cassar...
NHS in crisis: a pivotal moment for PMI?
Growing waiting lists and access issues in the NHS are prompting a new wave of interest in private healthcare among consumers, but can the...
What patients really want
Patient expectations are changing as advances in technology and increasing consumerisation transform the way care is delivered, but are healthcare providers responding to genuine shifts...
The next generation investing in cancer care
Dr Karen Sayal, oncology doctor and Dr Michelle Tempest, Candesic Partner, discuss how the growing market for cancer care, globalisation of care pathways and...
Looking back at lockdown
A new report published by IHPN examines how the sector has responded to the needs of the NHS during the first three months of...
NHS reform back on the agenda
IHPN CEO David Hare examines what the new White Paper
proposals mean for the independent healthcare sector
It’s been two years since NHS England first published...
A holistic approach to aesthetics
Lack of regulation and negative headlines have helped tarnish the reputation of aesthetic medicine in recent years, but it wasn’t always thus. Professor Steve...
The challenges and opportunities for UK dentistry
The UK dental market took a hit from Covid and remains challenged by staffing issues and economic headwinds but new research by Liz Heath...